Crystal deal toy commemorating a private placement by X4 Pharmaceuticals.
(21ALJ247)Crystal deal toy commemorating a private placement by X4 Pharmaceuticals.
(21ALJ247)Crystal deal toy commemorating Series A financing for Interius BioTherapeutics, a preclinical stage gene therapy firm.
(21AKL266)Crystal commemorative marking the initial public offering of Australian biotech firm Chimeric Therapeutics. The firm is developing a class of cell therapy drugs for the treatment of cancer.
(21ALJ210)Lucite tombstone commemorating crossover funding for AbSci, a Vancouver, Washington-based biotech firm.
(21ALJ163)Crystal deal tombstone celebrating the initial public offering of Arctic Bioscience. The Norwegian biotech firm makes use of bioactive marine compounds, including herring roe extracts.
(21LJW055)Custom financial tombstone commemorating an offering by Artelo Biosciences, a San Diego-based biopharmaceutical firm.
(20AJH203)Custom deal toy celebrating a follow-on public offering by Applied UV, a technology company employing narrow-range ultra violet light (UVC) to combat pathogens.
(20AJH232)Lucite tombstone celebrating Series A funding for Trailhead Biosystems. The Cleveland-based biotechnology company is focused on the application of machine-enabled technology.
(21ADH001)Lucite tombstone celebrating a private placement and concurrent global offering of shares by Calliditas Therapeutics. Joint bookrunners in the offering by the Swedish biotech firm were Citi, Jefferies, and Stifel.
(20ALJ348)